(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 57411.30 | 55948.80 | 2.61 | 57411.30 | 55948.80 | 2.61 | 207546.40 | 229774.00 | -9.67 |
| Other Income | 1401.70 | 1037.10 | 35.16 | 1401.70 | 1037.10 | 35.16 | 4193.30 | 3791.40 | 10.60 |
| PBIDT | 21043.80 | 20132.40 | 4.53 | 21043.80 | 20132.40 | 4.53 | 66000.20 | 72168.40 | -8.55 |
| Interest | 2784.80 | 2384.20 | 16.80 | 2784.80 | 2384.20 | 16.80 | 9478.40 | 9538.90 | -0.63 |
| PBDT | 17943.70 | 14871.80 | 20.66 | 17943.70 | 14871.80 | 20.66 | 51058.40 | 62629.50 | -18.48 |
| Depreciation | 3079.20 | 3109.20 | -0.96 | 3079.20 | 3109.20 | -0.96 | 13117.20 | 12867.40 | 1.94 |
| PBT | 14864.50 | 11762.60 | 26.37 | 14864.50 | 11762.60 | 26.37 | 37941.20 | 49762.10 | -23.75 |
| TAX | 3713.10 | 4312.00 | -13.89 | 3713.10 | 4312.00 | -13.89 | 11707.00 | 7481.30 | 56.48 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | 11151.40 | 7450.60 | 49.67 | 11151.40 | 7450.60 | 49.67 | 26234.20 | 42280.80 | -37.95 |
| Equity | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 |
| PBIDTM(%) | 36.65 | 35.98 | 1.86 | 36.65 | 35.98 | 1.86 | 31.80 | 31.41 | 1.25 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1989.35 |
| Dr. Reddys Labs. | 1147.60 |
| Cipla | 1472.95 |
| Lupin | 2413.95 |
| Zydus Lifesciences | 1126.50 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: